Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Post by Jthom376on May 12, 2021 11:16am

RE COVID-19

To date, the Corporation has: Completed safety studies that include GLP toxicology and confirmed a favourable safety profile; Completed preclinical immunogenicity studies showing potential for ...more  
246
Comment by Breakthoroughon May 12, 2021 9:40am

RE:RE:RE:Q1 Conference

If they update (asannounced) ovarian and Basket Trial, with proper data, and may be Spirel, it should be more rhan enough if data are good...
172
Discussion
Comment by Jthom376on May 12, 2021 9:34am

RE:RE:Q1 Conference

My opinion was that I don't see anytuing that will bring a nice recovery to this stock. It's not bad but I don't see a recovery this year. But we will see. Just opinion and would love to ...more  
156
Discussion
Comment by Breakthoroughon May 12, 2021 9:11am

RE:Q1 Conference

Don't get your point...: Selected Upcoming Milestones Maveropepimut-S Q2 2021: Beginning of Phase 2B DLBCL trial Q2 2021: Translational and biomarker clinical update for ovarian cancer Q3 2021 ...more  
275
Discussion
Post by Jthom376on May 12, 2021 8:56am

Q1 Conference

Doesn't seem to be any hope of recovery this year... COVID clinical studies have been all together removed from Q2. Still feels like a good long term INV if you were in at the current price ...more  
276
Discussion
Comment by gardyon May 11, 2021 2:15pm

RE:Same same old story

You nailed it on the head. This management team has become an epic failure for shareholders. What happened to Ovarian cancer, Animal health, Covid vacine ( what a joke ) etc, etc. Becoming nothing but ...more  
193
Discussion
Comment by 8inchlynchon May 11, 2021 9:14am

RE:Looks a pretty serious appointment

"Kalos" = "Good" in Greek...along with all these other pointslol
194
Discussion
Post by Breakthoroughon May 11, 2021 7:40am

Looks a pretty serious appointment

Most recently Dr. Kalos served as Executive Vice President and Head of R&D at ArsenalBio, a synthetic biology-based cell therapy start-up where he led development of R&D and product ...more  
263
Discussion
Post by Will101on May 10, 2021 4:54pm

Same same old story

Management is playing the same card again......Diverting attention to a new clinical trial with results WAAAAY into the future, while all the other stories pumped in the last few years are either ...more  
279
Discussion
Comment by Jthom376on May 10, 2021 1:29pm

RE:RE:RE:RE:New Trial in Breast Cancer

Curious if there is a precedence for who funds these independent studies. Just curious if anyone had some history with these.
144
Discussion
Comment by qwerty22on May 10, 2021 11:31am

RE:RE:RE:New Trial in Breast Cancer

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308147/ Seems like an interesting new population this trial is targeting.
168
Discussion
Comment by qwerty22on May 10, 2021 11:26am

RE:RE:New Trial in Breast Cancer

https://link.springer.com/article/10.1007/s10549-008-0164-5
159
Discussion
Comment by qwerty22on May 10, 2021 10:10am

RE:New Trial in Breast Cancer

Interesting. What can you say about this? Ph1, Investigator lead, so early and IMV have no control over it. A bunch of clinical scientists see the potential of dpx as a treatment in a different role ...more  
167
Discussion
Post by Breakthoroughon May 10, 2021 8:19am

New Trial in Breast Cancer

IMVs Lead Immunotherapy to be Investigated in Breast Cancer Study will evaluate maveropepimut-S (formerly known as DPX-Survivac) with an aromatase inhibitor, with/without radiotherapy or ...more  
254
Discussion
Comment by Jthom376on May 09, 2021 6:21pm

RE:RE:RE:RE:Anybody speak with management lately?

It was their fiscal 2020 financial report. So thru December 31 2020. I do believe they are being held up... otherwise they'd be foolish not to continue collecting free money. Maybe I'm wrong ...more  
180
Discussion
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities